Mylan N.V. is a global pharmaceutical company that develops, licenses, manufactures, markets, and distributes generic, branded generic, and specialty pharmaceuticals. The company operates in two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells, and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, cream, and ointment forms. The Specialty segment offers various branded specialty pharmaceuticals, including EpiPen Auto-Injector; Perforomist Inhalation Solution; Dymista; Creon; and Influvac, as well as YUPELRI, an inhalation solution for the maintenance treatment of patients with chronic obstructive pulmonary diseases.